Fred Alger Management’s vTv Therapeutics VTVT Stock Holding History

Fred Alger Management’s Portfolio VTVT Stock Details VTVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-25	Closed	-$6K	–	594
2017 Q3	$6K	Buy	+25	New	+$4.98K	﹤0.01%	482

Other funds holding VTVT

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fred Alger Management's VTVT Position: Q4 2017 in Review

Fred Alger Management sold out of vTv Therapeutics (VTVT) in Q4 2017, closing a stake of 25 shares — an estimated $6K sold.

Fred Alger Management first reported a position in VTVT in Q3 2017 and held it in 1 quarter. The position peaked at $6K in Q3 2017. 44 funds tracked by Wall St. Rank hold VTVT as of Q4 2017.

Fred Alger Management reported no remaining vTv Therapeutics position as of Q4 2017 after selling out during the quarter.
Fred Alger Management sold 25 vTv Therapeutics shares in Q4 2017, an estimated $6K.
Fred Alger Management first reported a position in vTv Therapeutics in Q3 2017 and held it in 1 quarter.
Fred Alger Management's vTv Therapeutics position peaked at $6K in Q3 2017.
44 funds tracked by Wall St. Rank held vTv Therapeutics as of Q4 2017.

Based on Fred Alger Management's 13F filing for Q4 2017, filed 14 Feb 2018.